[PDF][PDF] Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and …

…, J Raffoul, P Neven, Z Orosz, S Braye… - Journal of Clinical …, 2007 - researchgate.net
Prognostic and Predictive Value of Centrally Reviewed Expression of Estrogen and
Progesterone Receptors in a Randomized Trial Co Page 1 Prognostic and Predictive Value …

Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast …

G Viale, A Giobbie-Hurder, MM Regan… - Journal of clinical …, 2008 - ascopubs.org
Purpose To evaluate the prognostic and predictive value of Ki-67 labeling index (LI) in a trial
comparing letrozole (Let) with tamoxifen (Tam) as adjuvant therapy in postmenopausal …

[BOOK][B] Empowering practice in social care

S Braye - 1995 - books.google.com
This book provides a simple exposition of the concepts and value-base underpinning
community care policy and practice. Written in a jargon-free style, it goes beyond the how-to …

Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays

…, G Langman, L Mazzucchelli, S Braye… - Journal of the …, 2006 - academic.oup.com
Background: Tumor levels of steroid hormone receptors, a factor used to select adjuvant
treatment for early-stage breast cancer, are currently determined with immunohistochemical …

[HTML][HTML] Prognostic gene expression signature for high-grade serous ovarian cancer

…, J Rutovitz, P Clingan, A Glasgow, A Proietto, S Braye… - Annals of oncology, 2020 - Elsevier
Background Median overall survival (OS) for women with high-grade serous ovarian cancer
(HGSOC) is∼ 4 years, yet survival varies widely between patients. There are no well …

Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer …

…, KN Price, E Méry, M Lacroix-Triki, S Braye… - The lancet …, 2008 - thelancet.com
Summary Background The Breast International Group (BIG) 1-98 trial (a randomised double-
blind phase III trial) has shown that letrozole significantly improves disease-free survival …

Complexity and interprofessional education

H Cooper, S Braye, R Geyer - Learning in Health and Social …, 2004 - Wiley Online Library
Calls for greater collaboration between professionals in health and social care have led to
pressures to move towards interprofessional education at both pre‐and postregistration …

Key factors influencing the incidence of hemolysis: a critical appraisal of current evidence

…, L Li, L Burnett, D Chesher, S Braye… - Critical Reviews in …, 2017 - Taylor & Francis
Hemolysis is a leading cause of pre-analytical laboratory errors. The identification of
contributing factors is an important step towards the development of effective practices to …

'A mockery of equality': an exploratory investigation into disabled activists' views of the Paralympic Games

S Braye, K Dixon, T Gibbons - Disability & Society, 2013 - Taylor & Francis
This article offers an exploratory analysis of the opinions of disabled activists towards the
Paralympic Games. With the use of a qualitative online survey, the work focuses on the …

[HTML][HTML] Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancer

KA Avery-Kiejda, SG Braye, A Mathe, JF Forbes… - BMC cancer, 2014 - Springer
Background Breast cancer is the most common malignancy that develops in women,
responsible for the highest cancer-associated death rates. Triple negative breast cancers …